-

Phreesia Life Sciences Named one of MM+M’s “Best Places to Work 2021”

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia Life Sciences to its list of Best Places to Work 2021.

Now in its fourth year, the annual review spotlights the top healthcare marketing agencies and service providers that support the life sciences industry as rated by employees themselves. Phreesia was one of just two companies recognized in the “Large Companies/Service Providers” category and one of just 15 companies or agencies featured overall.

MM+M highlighted Phreesia’s collaborative, inclusive culture and its excellent benefits as standout features that make it a top-tier employer within the healthcare industry.

“We’re honored to receive this recognition from our employees of the work we’ve done to foster a supportive and inclusive culture,” Amy VanDuyn, SVP of Human Resources, said. “Phreesia Life Sciences is focused on hiring and retaining passionate, curious and energetic employees who are ready to transform the patient experience, and we’re thrilled to be named among the industry’s best destinations for talented individuals.”

Staffers gave Phreesia high marks for preparedness for working from home and applauded the way the company responded to COVID-19, noting that increased pay, stipends for home office supplies, summer Fridays and more kept morale high.

“I’m incredibly proud of the way Phreesia Life Sciences pivoted during the pandemic, not only to contribute to important and timely research and awareness efforts around crucial topics such as vaccine hesitancy, but also to foster a spirit of camaraderie and inclusivity while working remotely,” David Linetsky, SVP of Life Sciences, said.

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering targeted health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, and our PatientInsights product enables our clients to better understand their target patient populations.

Phreesia meets patients where they are, both virtually and in-person, and reaches them at multiple touchpoints throughout their healthcare journey. To learn more about Phreesia Life Sciences, visit lifesciences.phreesia.com.

Contacts

Media:
Carly Helfand
chelfand@phreesia.com
332-910-6768

Phreesia

NYSE:PHR

Release Versions

Contacts

Media:
Carly Helfand
chelfand@phreesia.com
332-910-6768

More News From Phreesia

Phreesia Announces Refinancing of Bridge Loan with New $275 Million Revolving Credit Facility

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") today announced the refinancing of its existing bridge loan (the “Bridge Loan”) by its entry into a new credit agreement providing for a senior secured revolving credit facility (the "New Credit Facility") of up to $275 million in aggregate principal amount, with Capital One, National Association (“Capital One”) serving as agent for the lenders. The Company borrowed approximately $92.2...

Phreesia’s Tiffany McGee Named a Top Woman Leader in Software

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that Tiffany McGee, Assistant General Counsel, Commercial Contracts, has been named to Top Women Leaders in Software....

Phreesia Named to the 2026 Capterra Shortlist for Appointment Scheduling

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to the 2026 Capterra Shortlist for Appointment Scheduling. The Capterra Shortlist is an independent assessment that uses a proprietary blend of user ratings and popularity signals to identify leading products across software categories. Phreesia was named to four Capterra Shortlists in 2025, including for Patient Engagement. “Recognition from Capterra is especially...
Back to Newsroom